ALEC Long Call Strategy

ALEC (Alector, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis diseases; and AL101 that is in Phase I clinical trial for the treatment of neurodegenerative diseases, including Alzheimer's and Parkinson's diseases. The company also offers AL002, a product candidate that is in Phase II clinical trial for the treatment of Alzheimer's disease; and AL003, which is in Phase I clinical trial for the treatment of Alzheimer's disease. In addition, its products in development stage include AL044 that targets MS4A4A, a risk gene for Alzheimer's disease. Alector, Inc. has a collaboration agreement with Adimab, LLC for the research and development of antibodies; and a strategic collaboration agreement with GlaxoSmithKline plc for the development and commercialization of monoclonal antibodies, such as AL001 and AL101 to treat neurodegenerative diseases. The company was founded in 2013 and is headquartered in South San Francisco, California.

ALEC (Alector, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $238.7M, a beta of 0.65 versus the broader market, a 52-week range of 1.01-3.4, average daily share volume of 721K, a public-listing history dating back to 2019, approximately 175 full-time employees. These structural characteristics shape how ALEC stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.65 indicates ALEC has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.

What is a long call on ALEC?

A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.

Current ALEC snapshot

As of May 15, 2026, spot at $2.21, ATM IV 125.60%, IV rank 24.74%, expected move 36.01%. The long call on ALEC below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.

Why this long call structure on ALEC specifically: ALEC IV at 125.60% is on the cheap side of its 1-year range, which favors premium-buying structures like a ALEC long call, with a market-implied 1-standard-deviation move of approximately 36.01% (roughly $0.80 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated ALEC expiries trade a higher absolute premium for lower per-day decay. Position sizing on ALEC should anchor to the underlying notional of $2.21 per share and to the trader's directional view on ALEC stock.

ALEC long call setup

The ALEC long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With ALEC near $2.21, the first option leg uses a $2.21 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed ALEC chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 ALEC shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Call$2.21N/A

ALEC long call risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.

ALEC long call payoff curve

Modeled P&L at expiration across a range of underlying prices for the long call on ALEC. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use long call on ALEC

Long calls on ALEC express a bullish thesis with defined risk; traders use them ahead of ALEC catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.

ALEC thesis for this long call

The market-implied 1-standard-deviation range for ALEC extends from approximately $1.41 on the downside to $3.01 on the upside. A ALEC long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current ALEC IV rank near 24.74% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on ALEC at 125.60%. As a Healthcare name, ALEC options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to ALEC-specific events.

ALEC long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. ALEC positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move ALEC alongside the broader basket even when ALEC-specific fundamentals are unchanged. Long-premium structures like a long call on ALEC are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current ALEC chain quotes before placing a trade.

Frequently asked questions

What is a long call on ALEC?
A long call on ALEC is the long call strategy applied to ALEC (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With ALEC stock trading near $2.21, the strikes shown on this page are snapped to the nearest listed ALEC chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are ALEC long call max profit and max loss calculated?
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the ALEC long call priced from the end-of-day chain at a 30-day expiry (ATM IV 125.60%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a ALEC long call?
The breakeven for the ALEC long call priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current ALEC market-implied 1-standard-deviation expected move is approximately 36.01%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a long call on ALEC?
Long calls on ALEC express a bullish thesis with defined risk; traders use them ahead of ALEC catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
How does current ALEC implied volatility affect this long call?
ALEC ATM IV is at 125.60% with IV rank near 24.74%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

Related ALEC analysis